FDA Clearance | sciencenewsnet.in

Breaking News

American Association of Immunologists (AAI) Introduces New Brand Identity

Stony coral tissue loss disease is shifting the ecological balance of Caribbean reefs

Metastatic Prostate Cancer Research: PSMAfore follow-on study favors radioligand therapy over change to androgen receptor pathway inhibition

May is Mental Health Awareness Month. Experts and Patients Available for Interviews on Trending Issues

ChatGPT can be helpful for Black women’s self-education about HIV, PrEP

Tip Sheet: Funding awarded to two ovarian cancer research projects, progress towards liquid biopsies for lung cancer — and cannabis and alcohol use in patients

A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss

Mexican researchers have found that people who avoid going to psychologists choose the most violent suicide methods

Genetics, not lack of oxygen, causes cerebral palsy in quarter of cases

Leveraging Holocaust History to Influence Modern Healthcare Practice, Ethics

04 May, 2024

Koya Medical Announces Topline Results from Its Latest Trial on the Treatment of Lower Extremity Lymphedema at VENOUS2024

March 6, 2024 sarah JonasAnnouncement

Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized cross-over study comparing lower extremity lymphedema treatment effectiveness of Dayspring®, Koya’s non-pneumatic compression device (NPCD) with a traditional advanced pneumatic compression device (APCD).

Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing

February 20, 2024 sarah JonasMarketplace

Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking eQUANTTM system.